 |
|
|
|
Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
| D | CDD-1 | 6EDM | 1.40 | 2019-08-14 | A0A160YKM3 | 31550535 | 10.1016/j.jsb.2019.09.008 | pdb | KCX SO4 | P 43 3 2 | 123.201 123.201 123.201 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 6PQC | 2.10 | 2019-10-09 | A0A160YKM3 | 31550535 | 10.1016/J.JSB.2019.09.008 | pdb | *CEF MES MPD SO4 | P 43 3 2 | 123.513 123.513 123.513 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7KEP | 1.92 | 2021-01-20 | A0A160YKM3 | 33390002 | 10.1021/ACSINFECDIS.0C00714 | pdb | FYG KCX MPD NXL SO4 | P 43 3 2 | 123.535 123.535 123.535 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7KEQ | 2.00 | 2021-01-20 | A0A160YKM3 | 33390002 | 10.1021/ACSINFECDIS.0C00714 | pdb | FYG KCX MPD NXL SO4 | P 43 3 2 | 123.536 123.536 123.536 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7KER | 1.93 | 2021-01-20 | A0A160YKM3 | 33390002 | 10.1021/ACSINFECDIS.0C00714 | pdb | EPE FYG KCX MPD NXL SO4 | P 43 3 2 | 124.184 124.184 124.184 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7LNO | 1.58 | 2021-05-12 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | KCX MPD SO4 | P 43 3 2 | 123.321 123.321 123.321 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7LNQ | 1.73 | 2021-05-12 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 KCX MPD SO4 | P 43 3 2 | 123.548 123.548 123.548 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7LNR | 1.83 | 2021-05-12 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL MPD SO4 | P 43 3 2 | 124.083 124.083 124.083 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7ME9 | 1.70 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | KCX MPD SO4 | P 43 3 2 | 123.489 123.489 123.489 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEA | 1.73 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL KCX MPD SO4 | P 43 3 2 | 123.668 123.668 123.668 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEB | 1.80 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 KCX MPD SO4 | P 43 3 2 | 123.584 123.584 123.584 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEC | 1.73 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 KCX MPD SO4 | P 43 3 2 | 123.352 123.352 123.352 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MED | 1.78 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 KCX MPD SO4 | P 43 3 2 | 123.436 123.436 123.436 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEE | 1.88 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 MPD SO4 | P 43 3 2 | 123.323 123.323 123.323 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEF | 1.90 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL CO2 MPD SO4 | P 43 3 2 | 123.803 123.803 123.803 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEG | 1.80 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL IMD MPD SO4 | P 43 3 2 | 123.571 123.571 123.571 ♦ 90.00 90.00 90.00 | 24 | |
| D | CDD-1 | 7MEH | 1.80 | 2022-02-16 | A0A160YKM3 | 33908775 | 10.1021/ACSINFECDIS.1C00094 | pdb | *NXL IMD MPD SO4 | P 43 3 2 | 123.673 123.673 123.673 ♦ 90.00 90.00 90.00 | 24 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: January 08, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database is funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu